The topics set out below reflect the specific themes the Conference will cover. The papers will set out specific policy recommendations in enough detail and with sufficient background and support to engender thoughtful evaluation and discussion at the Conference.
  • Private Regulation of Nanotechnology Panel (1)
    • Can industry self-regulation of nanotechnology provide effective, balanced protection of human health and the environment?
    • What form would effective industry self-regulation take (e.g. standards of conduct, certifications, information disclosure, etc.)?
    • Will industry self-regulation only operate effectively in the shadow of government regulation?
    • What role can the insurance industry play in private regulation of nanotechnology?
    • What role can private and public investors play in private regulation of nanotechnology?
  • Regulatory Policy for Nanotechnology Panels (2)
    • Is it too early to regulate nanotechnology, and if so, what steps should be taken to prepare for future regulation?
    • Are existing regulatory programs sufficient to regulate nanotechnology?
    • Can incremental amendments to existing regulatory programs provide adequate regulatory oversight for nanotechnology?
    • Given the level of scientific challenges to characterizing the hazards of nanotechnology, what is the optimal regulatory approach?
    • How should the precautionary principle be incorporated into regulatory policy for nanotechnology, if at all?
    • What are the appropriate roles for state and federal agencies in the regulation of nanotechnology?
    • Is the common law an effective regulatory mechanism for nanotechnology?